In this 23-year longitudinal study, by the age of 68 years, one-half of women with premature ovarian insufficiency/early menopause developed osteoporosis or a fracture.
Share
Menopause and the Role of Physical Activity - the Views and Knowledge of Women Aged 40-65
Source : https://pubmed.ncbi.nlm.nih.gov/38393976/
Menopause marks the end of female reproductive capacity. It is defined as the point after cessation of the menstrual cycle for 12 months (Nursat et al., 2008). Awareness about menopause...
This study found that women’s knowledge was not in line with their perceptions, perhaps in part due to where they are obtaining information.
Share
Treating Hot Flashes With Hypnosis: Does Hypnotizability Modulate Reductions?
Source : https://pubmed.ncbi.nlm.nih.gov/38265698
Hypnosis is an effective treatment option for a variety of concerns. Past research has suggested that those who score in the high range of hypnotizability initially show greater improvement than...
Participants who were rated as either moderately or highly hypnotizable achieved a 50% reduction by Week 3 while those of low hypnotizability did not cross the 50% reduction threshold until the 12-week follow-up.
Share
The impact of 17β-Estradiol on the Estrogen-Deficient Female Brain: From Mechanisms to Therapy With Hot Flushes as Target Symptoms
Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800853/
Sex steroids are essential for whole body development and functions. Among these steroids, 17β-estradiol (E2) has been known as the principal "female" hormone. However, E2's actions are not restricted to...
A noninvasive DHED prodrug approach may offer a translational value in terms of defining a therapeutic landscape to remedy the E2-deficient brain safely and efficaciously, including the alleviation or prevention of VMS.
Share
Obesity and Menopause
Source : https://pubmed.ncbi.nlm.nih.gov/38343134/
Obesity is not a choice or a result of lack of willpower, but a multifactorial, chronic, progressive, and relapsing disease. During menopause, hormonal and body composition changes lead to greater...
The use of estrogen-only or combined transdermal MHT does not increase the risk of thrombotic events in women with obesity.
Share